Literature DB >> 20395530

Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system.

Hee Jin Lee1, Jene Choi, Tae Sook Hwang, Young Kee Shong, Suck Joon Hong, Gyungyub Gong.   

Abstract

With various methods, BRAF mutations have been detected in 73.4% to 87.1% of papillary thyroid carcinomas (PTCs) in Korea. We assessed the ability of allele-specific polymerase chain reaction using a dual priming oligonucleotide system, compared with direct sequencing and pyrosequencing, to detect BRAF mutations in fine-needle aspiration specimens from 85 patients undergoing thyroidectomy. Final pathologic diagnoses were 55 malignant lesions and 30 benign lesions. We detected BRAF mutations in 47 (90%) of 52 PTCs by at least 1 method. The sensitivity of the dual priming oligonucleotide system (88.5%) was slightly higher than that of direct sequencing (82.7%) and pyrosequencing (86.5%). The specificity and positive predictive value of all 3 methods were 100%. The dual priming oligonucleotide system is a simple, rapid, and reliable method for detecting BRAF mutations. This method may be a useful adjunct tool to improve the preoperative diagnostic accuracy of PTC in fine-needle aspiration biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395530     DOI: 10.1309/AJCPO3F2ENKMDTUS

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  15 in total

1.  Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance.

Authors:  Eun Kyung Jang; Won Gu Kim; Eui Young Kim; Hyemi Kwon; Yun Mi Choi; Min Ji Jeon; Jung Hwan Baek; Jeong Hyun Lee; Tae Yong Kim; Young Kee Shong; Jene Choi; Dong Eun Song; Won Bae Kim
Journal:  Endocrine       Date:  2015-11-07       Impact factor: 3.633

2.  High-Resolution Melting Is a Sensitive, Cost-Effective, Time-Saving Technique for BRAF V600E Detection in Thyroid FNAB Washing Liquid: A Prospective Cohort Study.

Authors:  Marco Marino; Maria Laura Monzani; Giulia Brigante; Katia Cioni; Bruno Madeo; Daniele Santi; Antonino Maiorana; Stefania Bettelli; Valeria Moriondo; Elisa Pignatti; Lara Bonacini; Cesare Carani; Vincenzo Rochira; Manuela Simoni
Journal:  Eur Thyroid J       Date:  2015-05-30

3.  Proficiency of DNA repair genes and microsatellite instability in operated colorectal cancer patients with clinical suspicion of lynch syndrome.

Authors:  Isabella Nicácio de Freitas; Fábio Guilherm Caserta Maryssael de Campos; Venâncio Avancini Ferreira Alves; Juliana Magalhães Cavalcante; Dirce Carraro; Renata de Almeida Coudry; Márcio Augusto Diniz; Sérgio Carlos Nahas; Ulysses Ribeiro
Journal:  J Gastrointest Oncol       Date:  2015-12

4.  BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.

Authors:  Ahmet Şahpaz; Binnur Önal; Ahmet Yeşilyurt; Ünsal Han; Tuncay Delibaşı
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

5.  The prognostic relevance of psammoma bodies and ultrasonographic intratumoral calcifications in papillary thyroid carcinoma.

Authors:  Jung-Soo Pyo; Guhyun Kang; Dong-Hoon Kim; Chanheun Park; Joo Heon Kim; Jin Hee Sohn
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

6.  Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.

Authors:  Ronald A Ghossein; Nora Katabi; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2013-06-17       Impact factor: 5.958

7.  Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.

Authors:  Jonathan Zagzag; Aron Pollack; Linda Dultz; Shumon Dhar; Jennifer B Ogilvie; Keith S Heller; Fang-Ming Deng; Kepal N Patel
Journal:  Surgery       Date:  2013-08-06       Impact factor: 3.982

Review 8.  BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAF(V600E) Mutation Test in Papillary Thyroid Carcinoma.

Authors:  Jung-Soo Pyo; Jin Hee Sohn; Guhyun Kang
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

9.  Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing.

Authors:  Dongjun Jeong; Yujun Jeong; Sungche Lee; Hyeran Lee; Wanju Lee; Hyungjoo Kim; Doosan Park; Soyoung Park; Wenxia Mu; Hyun-Deuk Cho; Mee-Hye Oh; Sung Soo Lee; Seung-Ha Yang; Chang-Jin Kim
Journal:  Korean J Pathol       Date:  2012-02-23

Review 10.  B-Raf and the inhibitors: from bench to bedside.

Authors:  Tiangui Huang; Michael Karsy; Jian Zhuge; Minghao Zhong; Delong Liu
Journal:  J Hematol Oncol       Date:  2013-04-25       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.